Premium
Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer
Author(s) -
Jumeau Raphael,
Peguret Nicolas,
Bari Berardino,
Moeckli Raphael,
SoaresRodrigues JoaoLuis,
Durham Andrea Dante,
Hojnowski Sophie,
Bourhis Jean,
Ozsahin Mahmut,
BeigelmanAubry Catherine
Publication year - 2017
Publication title -
journal of medical imaging and radiation oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.31
H-Index - 43
eISSN - 1754-9485
pISSN - 1754-9477
DOI - 10.1111/1754-9485.12516
Subject(s) - medicine , tomotherapy , radiation treatment planning , lung cancer , nuclear medicine , lung , radiation therapy , lung volumes , pulmonary function testing , radiology
Currently, routine radiotherapy ( RT ) planning for locally advanced lung cancer ( LC ) does not take into consideration the functional state of the lung. The goal of this study was to determine if it is technically feasible to integrate the sites of pulmonary emphysema ( PE ) into the RT planning process. Methods Ten patients with LC and PE treated with helical Tomotherapy© were retrospectively included. After extraction by Myrian© software based on diagnostic CT ( DCT ), the PE data were transferred to the treatment planning system ( TPS ). PE ‐optimized plans were performed for patients with significant PE , where the dose was focused onto the PE . We compared the PE ‐optimized RT plans to the initial RT plans. Results The median dose to the planning target volume ( PTV ) was 52 Gy (range, 36–66) in fractions of 2–3 Gy. The median PE volume was 220 cm 3 (range: 12–1394), and six patients were eligible for a PE ‐optimized RT plan. Considering the lung without PE , the V20 and V30 variations were not significant ( P > 0.05), the V5 decreased from 50% to 44% after re‐planning ( P < 0.05). The mean PTV D98 was 50 Gy versus 48 Gy ( P < 0.05). Conclusion Focusing the RT beam flow on the PE structure rather than the healthy lung appears feasible, and may be a promising technique to help preserve pulmonary function and minimize RT ‐related pulmonary toxicity.